Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Transcatheter Mitral Valve Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?#_x000D_
The transcatheter mitral valve market has shown strong growth in recent years. It is projected to increase from $1.61 billion in 2025 to $1.76 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.3%. The expansion observed historically can be linked to factors such as the restricted availability of transcatheter mitral valves, a reliance on surgical valve replacement, increased awareness of mitral valve disease, a rise in hospital cardiac procedures, and early adoption among high-risk patient groups._x000D_
_x000D_
The transcatheter mitral valve market is projected to see significant expansion in the near future, reaching $2.49 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.0%. This growth is attributable to several factors, including technological advancements in transcatheter valve designs, a rising geriatric population afflicted with mitral valve disorders, the increasing establishment of cardiac catheterization laboratories, greater healthcare expenditure, and the growing adoption of minimally invasive cardiac intervention programs. Key trends expected over the forecast period encompass the increasing acceptance of minimally invasive cardiac procedures, expanded utilization of self-expanding and balloon-expandable valves, the proliferation of edge-to-edge and chordal repair devices, a heightened prevalence of mitral valve diseases among elderly patients, and the integration of imaging and navigation systems for enhanced procedure accuracy._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Transcatheter Mitral Valve Market Growth Momentum: What Factors Are Shaping Demand?#_x000D_
The escalating incidence of heart diseases is anticipated to spur the expansion of the transcatheter mitral valve market in the future. Cardiac ailments are conditions that interfere with the heart’s structure or how it functions, diminishing its efficiency in pumping blood. The heightened occurrence of heart diseases is fueled by aging populations, as the age-related deterioration of the heart and blood vessels increases vulnerability to conditions such as mitral valve regurgitation, heart failure, and arrhythmias. A transcatheter mitral valve assists in treating heart disease by repairing or replacing a damaged mitral valve to reestablish proper blood flow between the heart’s chambers, thereby enhancing cardiac performance and alleviating symptoms. For instance, in August 2025, according to the National Center for Biotechnology Information, a US-based governmental agency, cardiovascular disease is projected to rise significantly between 2025 and 2050, with prevalence increasing by 90.0%, crude mortality by 73.4%, and crude DALYs by 54.7%, leading to an estimated 35.6 million cardiovascular deaths in 2050, up from 20.5 million in 2025. Consequently, the rising prevalence of heart diseases is fostering the growth of the transcatheter mitral valve market._x000D_
_x000D_
#Transcatheter Mitral Valve Market Segment Analysis And Revenue Potential#_x000D_
The transcatheter mitral valve market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Transcatheter Mitral Valve Replacement, Transcatheter Mitral Valve Repair_x000D_
2) By Indication: Mitral Stenosis, Mitral Regurgitation_x000D_
3) By End-User: Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories_x000D_
_x000D_
Subsegments:_x000D_
1) By Transcatheter Mitral Valve Replacement: Self-Expanding Valves, Balloon-Expandable Valves_x000D_
2) By Transcatheter Mitral Valve Repair: Annuloplasty Devices, Chordal Repair Devices, Edge-To-Edge Repair Devices_x000D_
_x000D_
#Transcatheter Mitral Valve Market Trends Redefining Industry Growth#_x000D_
Companies operating in the transcatheter mitral valve market are strategically developing advanced products, such as transcatheter mitral valve replacement systems, to expand treatment options for patients who are high-risk or deemed inoperable. Transcatheter mitral valve replacement (TMVR) systems are characterized as minimally invasive medical devices that replace a damaged or diseased mitral valve in the heart with an artificial valve through a catheter-based approach, thereby eliminating the need for open-heart surgery. As an illustration, in May 2025, Abbott Laboratories, a US-based medical device company, introduced Tendyne after securing approval from the Food and Drug Administration (FDA). Tendyne is a self-expanding, nitinol-framed valve offered in multiple sizes to accommodate diverse anatomies and can be completely repositioned or retrieved during implantation. Delivered through a small incision in the chest, the system facilitates a minimally invasive procedure typically concluded in about 1.5 hours. Engineered for rapid recovery, this system allows most patients to be discharged within three days, presenting a transformative solution for high-risk mitral valve patients who lack viable surgical alternatives._x000D_
_x000D_
#Transcatheter Mitral Valve Market Competitive Landscape: Who Leads The Industry?#_x000D_
Major companies operating in the transcatheter mitral valve market are Abbott Laboratories, Medtronic Inc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Meril Life Sciences Private Limited, MicroPort Scientific Corporation, Venus Medtech Inc., Cardiac Dimensions Inc., JenaValve Technology Inc., Ancora Heart Inc, Peijia Medical Limited, Micro Interventional Devices Inc., 4C Medical Technologies Inc., NeoChord Inc., Xeltis AG, Valcare Medical Inc., Colibri Heart Valve LLC, MitrAssist Ltd., HighLife SAS, Navigate Cardiac Structures Inc., Cardiovalve Ltd. _x000D_
_x000D_
#View The Full Transcatheter Mitral Valve Market Report:#_x000D_
_x000D_
#Transcatheter Mitral Valve Market Geographic Landscape: Which Region Leads Industry Growth?#_x000D_
North America was the largest region in the transcatheter mitral valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcatheter mitral valve market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.